Obesity Treatment Market Size, Growth, Insight & Analysis [2020-2027]
Obesity Treatment Market Overview
The global obesity treatment market size is expected to
grow at an approximate CAGR of 16.7% during the forecast period.
Request Free
Sample Copy at:
https://www.marketresearchfuture.com/sample_request/5872
Obesity
Treatment Market Segmentation
The global
obesity treatment market is segmented on the basis of type, diagnosis,
treatment, and end-user.
On the basis of
types, the market is segmented into inactivity obesity, food obesity, anxiety
obesity, venous obesity, atherogenic obesity, and gluten obesity.
On the basis of
diagnosis, the market is categorized into blood tests, physical examination,
and others. The blood tests segment is sub-segmented into cholesterol test,
liver function test, thyroid test, and others.
The physical examination segment is sub-segmented into heart rate
measurement, blood pressure measurement, and others.
On the basis of
treatment, the market is segmented into medication, surgery, lifestyle changes,
and others. The medication segment is sub-segmented into orlistat, lorcaserin,
phentermine and topiramate, liraglutide, and others. The surgery segment is
sub-segmented into gastric bypass surgery, Laparoscopic Adjustable Gastric
Banding (LAGB), gastric sleeve, biliopancreatic diversion, gastric sleeve, and
others.
On the basis of
end-users, the market is segmented into hospitals, clinics, pharmacies, and
others.
Obesity
Treatment Market Regional Analysis
The Americas
dominates the global obesity treatment market. The increasing obese population,
the presence of a well-developed healthcare sector, and presence of developed
economies such as the U.S. and Canada are the drivers for the market growth
within the region. Additionally, increasing healthcare expenditures and
presence of market players such as Medtronic, Mediflex Surgical Products, Johnson
& Johnson Services, Inc., and others within the Americas boost the regional
growth of the market. Europe is second in the global obesity treatment market
owing to the availability of funds for research, growing obese population, and
increasing adoption of bariatric surgeries within the region. Asia Pacific is
estimated to be the fastest growing region. This can be attributed to the
increasing obese population, presence of developing economies, and a growing
healthcare sector within the region. On
the other hand, the Middle East and Africa holds the least share in the global
obesity treatment market. The presence of poor economies and stringent
government policies especially within the Africa region restrict the regional
market growth.
Obesity
Treatment Market Players
·
Globus Medical, Inc. (U.S.)
·
Depuy Synthes Inc. (Johnson & Johnson) (U.S.)
·
Smith & Nephew plc. (UK)
·
NuVasive, Inc. (U.S.)
·
Stryker Corporation (U.S.)
·
Integra LifeSciences Holdings Corporation (U.S.)
·
Zimmer Biomet Holdings, Inc. (U.S.)
·
Medtronic, plc (Ireland)
·
Wright Medical Group N.V. (Netherlands)
·
The Orthopedic Implant Company (U.S.)
·
Aesculap Implant Systems (U.S.)
·
Conmed Corporation (U.S.)
·
BioTek Instruments, Inc. (U.S.)
·
Arthrocare Corporation (U.S.)
among others
are some key companies in the global obesity treatment that are listed by MRFR
for market research.
Browse Detailed
TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/obesity-treatment-market-5872
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private
Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Comments
Post a Comment